Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership290,360 shares
Latest Disclosed Value $ 810,104
Citadel Advisors Llc ownership in PHPN / Galectin Therapeutics Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 290,360 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $650,406 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Galectin Therapeutics Inc.. The current value of the position is $545,877 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (PHPN) in the form of stock options. The firm currently holds call options representing 32,800 of underlying shares valued at $91,512 USD and put options representing 40,200 of underlying shares valued at $112,158 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:PHPN / Galectin Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 290,360 290,360 810 0.0001
2026-02-17 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -71,306 -100.00 0 -100.00
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 71,306 -31,991 -30.97 302 38.71 0.0000
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 103,297 103,297 218 0.0000
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -823 -100.00 0 -100.00
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 823 -23,698 -96.64 2 -98.28 0.0000
2024-05-15 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 24,521 17,511 249.80 59 427.27 0.0000
2024-02-14 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 7,010 7,010 12 0.0000
2023-11-14 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -428 -100.00 0 0.0000
2023-08-14 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 428 -850 -66.51 1 -100.00 0.0000
2023-05-15 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 1,278 -82,356 -98.47 3 -97.87 0.0000
2023-02-14 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 83,634 65,494 361.05 95 224.14 0.0000
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW 363225202 18,140 18,140 29 0.0000
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 0 -43,382 -100.00 0 -100.00
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 43,382 18,950 77.56 90 -5.26 0.0000
2021-11-15 2021-09-30 13F GALECTIN THERAPEUTICS Cmn 363225202 24,432 24,432 95 0.0000
2021-05-21 2021-03-31 13F/A-1 GALECTIN THERAPEUTICS COM NEW 363225202 0 -19,333 -100.00 0 -100.00
2021-02-16 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW 363225202 19,333 19,333 43 0.0000
2020-11-16 2020-09-30 13F GALECTIN THERAPEUTICS Cmn 363225202 0 -15,383 -100.00 0 -100.00
2020-08-14 2020-06-30 13F GALECTIN THERAPEUTICS Cmn 363225202 15,383 -36,220 -70.19 47 -53.47 0.0000
2020-05-15 2020-03-31 13F GALECTIN THERAPEUTICS Cmn 363225202 51,603 40,512 365.27 101 215.63 0.0000
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS Cmn 363225202 11,091 -7,955 -41.77 32 -54.29 0.0000
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS Cmn 363225202 19,046 19,046 71.72 70 118.75 0.0000
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS Cmn 363225202 0 -20,411 -100.00 0 -100.00
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS Cmn 363225202 20,411 -316 -1.52 104 46.48 0.0001
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS Cmn 363225202 20,727 20,727 1.55 71 -31.73 0.0000
2018-11-13 2018-09-30 13F GALECTIN THERAPEUTICS Cmn 363225202 0 -23,399 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 GALECTIN THERAPEUTICS Cmn 363225202 23,399 -44,147 -65.36 149 -53.44 0.0001
2018-08-10 2018-06-30 13F GALECTIN THERAPEUTICS Cmn 363225202 23,399 -44,147 149
2018-05-14 2018-03-31 13F/A-1 GALECTIN THERAPEUTICS Cmn 363225202 67,546 67,546 188.67 320 114.77 0.0002
2018-05-11 2018-03-31 13F GALECTIN THERAPEUTICS Cmn 363225202 67,546 67,546 320
2017-11-09 2017-09-30 13F GALECTIN THERAPEUTICS Cmn 363225202 0 -13,300 -100.00 0 -100.00
2017-08-11 2017-06-30 13F GALECTIN THERAPEUTICS Cmn 363225202 13,300 -21,409 -61.68 33 -58.75 0.0000
2017-05-12 2017-03-31 13F GALECTIN THERAPEUTICS Cmn 363225202 34,709 34,709 160.97 80 142.42 0.0001
2017-02-10 2016-12-31 13F GALECTIN THERAPEUCTICS Cmn 363225202 0 -25,771 -100.00 0 -100.00
2017-01-31 2016-09-30 13F/A-1 GALECTIN THERAPEUTICS Cmn 363225202 25,771 11,935 86.26 29 45.00 0.0000
2016-11-10 2016-09-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 25,771 29
2017-01-31 2016-06-30 13F/A-1 GALECTIN THERAPEUTICS Cmn 363225202 13,836 13,836 -46.31 20 -31.03 0.0000
2016-08-12 2016-06-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 13,836 20
2016-02-12 2015-12-31 13F GALECTIN THERAPEUCTICS Cmn 363225202 0 -8,809 -100.00 0 -100.00
2015-11-16 2015-09-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 8,809 -1,957 -18.18 21 -27.59 0.0000
2015-08-14 2015-06-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 10,766 10,766 22.22 29 38.10 0.0000
2015-05-15 2015-03-31 13F GALECTIN THERAPEUCTICS Cmn 363225202 0 -6,906 -100.00 0 -100.00
2015-02-17 2014-12-31 13F GALECTIN THERAPEUCTICS Cmn 363225202 6,906 -13,112 -65.50 24 -76.24 0.0000
2014-11-14 2014-09-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 20,018 17,320 641.96 101 172.97 0.0001
2014-08-14 2014-06-30 13F GALECTIN THERAPEUCTICS Cmn 363225202 2,698 2,698 37 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 32,800 19.27 92 -20.18 n/a n/a n/a
2026-02-17 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 27,500 -61.96 114 -62.75 n/a n/a n/a
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 72,300 4.63 306 111.03 n/a n/a n/a
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 69,100 -41.74 146 0.69 n/a n/a n/a
2025-05-15 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 118,600 -79.51 145 -80.70 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 578,700 825.92 747 336.26 n/a n/a n/a
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 62,500 359.56 172 470.00 n/a n/a n/a
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 13,600 76.62 31 66.67 n/a n/a n/a
2024-05-15 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 7,700 133.33 18 260.00 n/a n/a n/a
2024-02-14 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 3,300 5 n/a n/a n/a
2023-11-14 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 9,700 -44.89 14 -63.89 n/a n/a n/a
2023-05-15 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 17,600 5,766.67 37 n/a n/a n/a
2023-02-14 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 300 0 n/a n/a n/a
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 22,800 -70.73 37 -77.02 n/a n/a n/a
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 77,900 -7.81 161 -50.91 n/a n/a n/a
2021-11-15 2021-09-30 13F GALECTIN THERAPEUTICS Cmn Call 84,500 49.03 328 81.22 n/a n/a n/a
2021-08-16 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Call 56,700 131.43 181 241.51 n/a n/a n/a
2021-05-21 2021-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Call 24,500 -52.79 53 -54.31 n/a n/a n/a
2021-05-17 2021-03-31 13F GALECTIN THERAPEUTICS COM NEW Call 24,500 53 n/a n/a n/a
2021-02-16 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW Call 51,900 25.97 116 5.45 n/a n/a n/a
2020-11-16 2020-09-30 13F GALECTIN THERAPEUTICS COM NEW Call 41,200 18.05 110 2.80 n/a n/a n/a
2020-08-14 2020-06-30 13F GALECTIN THERAPEUTICS Cmn Call 34,900 -14.67 107 33.75 n/a n/a n/a
2020-05-15 2020-03-31 13F GALECTIN THERAPEUTICS Cmn Call 40,900 -15.32 80 -42.03 n/a n/a n/a
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS Cmn Call 48,300 -9.38 138 -29.59 n/a n/a n/a
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS Cmn Call 53,300 60.54 196 42.03 n/a n/a n/a
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS Cmn Call 33,200 -58.03 138 -65.84 n/a n/a n/a
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS Cmn Call 79,100 -15.94 404 25.08 n/a n/a n/a
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS Cmn Call 94,100 17.62 323 -32.85 n/a n/a n/a
2018-11-13 2018-09-30 13F GALECTIN THERAPEUTICS Cmn Call 80,000 146.15 481 132.37 n/a n/a n/a
2018-08-14 2018-06-30 13F/A GALECTIN THERAPEUTICS Cmn Call 32,500 103.12 207 172.37 n/a n/a n/a
2018-08-10 2018-06-30 13F GALECTIN THERAPEUTICS Cmn Call 32,500 207 n/a n/a n/a
2018-05-14 2018-03-31 13F/A GALECTIN THERAPEUTICS Cmn Call 16,000 -48.72 76 -26.92 n/a n/a n/a
2018-05-11 2018-03-31 13F GALECTIN THERAPEUTICS Cmn Call 16,000 76 n/a n/a n/a
2018-02-09 2017-12-31 13F GALECTIN THERAPEUTICS Cmn Call 31,200 47.17 104 131.11 n/a n/a n/a
2017-11-09 2017-09-30 13F GALECTIN THERAPEUTICS Cmn Call 21,200 -60.52 45 -65.91 n/a n/a n/a
2017-08-11 2017-06-30 13F GALECTIN THERAPEUTICS Cmn Call 53,700 -3.59 132 3.13 n/a n/a n/a
2017-05-12 2017-03-31 13F GALECTIN THERAPEUTICS Cmn Call 55,700 44.30 128 236.84 n/a n/a n/a
2017-02-10 2016-12-31 13F GALECTIN THERAPEUTICS Cmn Call 38,600 49.03 38 31.03 n/a n/a n/a
2017-01-31 2016-09-30 13F/A GALECTIN THERAPEUTICS Cmn Call 25,900 -32.90 29 -23.68 n/a n/a n/a
2016-11-10 2016-09-30 13F GALECTIN THERAPEUCTICS Cmn Call 25,900 29 n/a n/a n/a
2015-11-16 2015-09-30 13F GALECTIN THERAPEUCTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F GALECTIN THERAPEUCTICS Cmn Call 1,300 4 n/a n/a n/a
2015-05-15 2015-03-31 13F GALECTIN THERAPEUCTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F GALECTIN THERAPEUCTICS Cmn Call 1,000 -92.25 3 -95.38 n/a n/a n/a
2014-11-14 2014-09-30 13F GALECTIN THERAPEUCTICS Cmn Call 12,900 -42.92 65 -79.17 n/a n/a n/a
2014-08-14 2014-06-30 13F GALECTIN THERAPEUCTICS Cmn Call 22,600 -40.68 312 -46.48 n/a n/a n/a
2014-05-15 2014-03-31 13F GALECTIN THERAPEUCTICS Cmn Call 38,100 583 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 40,200 112 n/a n/a n/a
2026-02-17 2025-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 12,400 -77.37 53 -54.78 n/a n/a n/a
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 54,800 -49.95 116 -13.53 n/a n/a n/a
2025-05-15 2025-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 109,500 39.67 134 31.68 n/a n/a n/a
2025-02-14 2024-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 78,400 51.94 101 -28.37 n/a n/a n/a
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 51,600 1,811.11 142 2,250.00 n/a n/a n/a
2024-08-14 2024-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 2,700 6 n/a n/a n/a
2024-05-15 2024-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 4,400 7 n/a n/a n/a
2023-11-14 2023-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 2,400 -27.27 3 -50.00 n/a n/a n/a
2023-05-15 2023-03-31 13F GALECTIN THERAPEUTICS COM NEW Put 3,300 -26.67 7 20.00 n/a n/a n/a
2023-02-14 2022-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 4,500 5 n/a n/a n/a
2022-11-14 2022-09-30 13F GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 10,700 14 n/a n/a n/a
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F GALECTIN THERAPEUTICS Cmn Put 18,400 -12.80 71 4.41 n/a n/a n/a
2021-08-16 2021-06-30 13F GALECTIN THERAPEUTICS COM NEW Put 21,100 68 n/a n/a n/a
2021-05-21 2021-03-31 13F/A GALECTIN THERAPEUTICS COM NEW Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F GALECTIN THERAPEUTICS COM NEW Put 10,000 22 n/a n/a n/a
2020-05-15 2020-03-31 13F GALECTIN THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS Cmn Put 19,200 -46.67 55 -58.33 n/a n/a n/a
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS Cmn Put 36,000 10.77 132 -2.22 n/a n/a n/a
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS Cmn Put 32,500 -9.72 135 2.27 n/a n/a n/a
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS Cmn Put 20,300 -43.14 70 -67.44 n/a n/a n/a
2018-11-13 2018-09-30 13F GALECTIN THERAPEUTICS Cmn Put 35,700 -27.29 215 -31.09 n/a n/a n/a
2018-08-14 2018-06-30 13F/A GALECTIN THERAPEUTICS Cmn Put 49,100 175.84 312 271.43 n/a n/a n/a
2018-08-10 2018-06-30 13F GALECTIN THERAPEUTICS Cmn Put 49,100 312 n/a n/a n/a
2018-05-14 2018-03-31 13F/A GALECTIN THERAPEUTICS Cmn Put 17,800 -13.59 84 21.74 n/a n/a n/a
2018-05-11 2018-03-31 13F GALECTIN THERAPEUTICS Cmn Put 17,800 84 n/a n/a n/a
2018-02-09 2017-12-31 13F GALECTIN THERAPEUTICS Cmn Put 20,600 15.73 69 -17.86 n/a n/a n/a
2016-02-12 2015-12-31 13F GALECTIN THERAPEUCTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-16 2015-09-30 13F GALECTIN THERAPEUCTICS Cmn Put 2,900 -47.27 7 -53.33 n/a n/a n/a
2015-08-14 2015-06-30 13F GALECTIN THERAPEUCTICS Cmn Put 5,500 89.66 15 114.29 n/a n/a n/a
2015-05-15 2015-03-31 13F GALECTIN THERAPEUCTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F GALECTIN THERAPEUCTICS Cmn Put 6,000 -57.45 21 -70.42 n/a n/a n/a
2014-11-14 2014-09-30 13F GALECTIN THERAPEUCTICS Cmn Put 14,100 93.15 71 -29.70 n/a n/a n/a
2014-08-14 2014-06-30 13F GALECTIN THERAPEUCTICS Cmn Put 7,300 -54.38 101 -58.78 n/a n/a n/a
2014-05-15 2014-03-31 13F GALECTIN THERAPEUCTICS Cmn Put 16,000 245 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.